|
|
| AAKG1_HUMAN |
PRKAG1 |
5'-AMP-activated protein kinase subunit gamma-1 |
1.046e-42 |
0.40
|
| AAPK2_HUMAN |
PRKAA2 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 |
2.519e-39 |
0.40
|
| AAKB1_HUMAN |
PRKAB1 |
5'-AMP-activated protein kinase subunit beta-1 |
4.869e-38 |
0.40
|
| AAKG2_HUMAN |
PRKAG2 |
5'-AMP-activated protein kinase subunit gamma-2 |
1.215e-35 |
0.28
|
| TFDP2_HUMAN |
TFDP2 |
Transcription factor Dp-2 |
1.215e-35 |
0.28
|
| AAKG3_HUMAN |
PRKAG3 |
5'-AMP-activated protein kinase subunit gamma-3 |
5.889e-23 |
0.28
|
| AAKB2_HUMAN |
PRKAB2 |
5'-AMP-activated protein kinase subunit beta-2 |
8.52e-18 |
0.28
|
| THIO_HUMAN |
TXN |
Thioredoxin |
1.11e-16 |
0.34
|
| CCG8_HUMAN |
CACNG8 |
Voltage-dependent calcium channel gamma-8 subunit |
1.554e-15 |
0.30
|
| Q9RMI3_STAAU |
fabI |
Enoyl-[acyl-carrier-protein] reductase [NADPH] |
1.41e-14 |
0.32
|
| OPRX_HUMAN |
OPRL1 |
Nociceptin receptor |
8.197e-09 |
0.37
|